跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ARX-PIRFENIDONE pirfenidone 267 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
ARX-PIRFENIDONE pirfenidone 267 mg tablet blister pack
Approved
STANDARD
ARX-PIRFENIDONE pirfenidone 267 mg tablet blister pack
Cipla Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
9f54d9a359c1b91d
Company
Cipla Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
9f54d9a359c1b91d
Product Name
ARX-PIRFENIDONE pirfenidone 267 mg tablet blister pack
Artg Id
405524
Artg Name
ARX-PIRFENIDONE pirfenidone 267 mg tablet blister pack
Sponsor
Cipla Australia Pty Ltd
Company Detail Path
/organization/cipla-australia-pty-ltd
Artg Date
2023-12-01
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2025-CMI-01397-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-PI-02664-1
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
9f54d9a359c1b91d
Type
Standard
Back to TGA Approvals